The Attention Shift: What Pharmaceutical Media Must Rethink
Patient attention hasn’t declined — it has fundamentally changed.
In today’s digital health landscape, exposure no longer guarantees attention, and impressions no longer signal trust. Patients increasingly engage with health information selectively, gravitating toward environments where relevance, context, and credibility align with their lived experience.
This white paper explores where patient attention is actually formed in 2026, why traditional reach-based media models are losing effectiveness, and how contextual, conversational, and condition-level engagement delivers stronger signals and more durable impact.
Download the white paper to learn:
Why attention is shaped by context, not volume
How condition-specific environments outperform broad media placements
What sustained attention means for pharmaceutical media strategy
How agencies can move beyond impressions to higher-quality engagement signals